Medication info

Ranozol 15 mg (Rabeprazole)

Prescription medicationTabletOralExpired
Ingredient · strength
Lansoprazole›15mg / 1 tablet
Manufacturer / importer
Samil Pharmaceutical Co., Ltd.
Appearance
Brownish-red round enteric-coated tablet
Packaging
28 tablets/bottle
Approval status
Expired

MFDS item code 200600138 · Notified 2006.02.17

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of peptic ulcers, treatment of gastroesophageal reflux disease, and suppression of pathological gastric acid hypersecretion
Who takes it
Adults
Adult dose
This medicine should be administered before meals. After opening, do not chew or crush this medicine before taking it. Adults 1. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. 2. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. 3. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer 1) Administer lansoprazole 30 mg together with clarithromycin 250 ∼ 500 mg and amoxicillin 1000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days, as needed. 2) Administer lansoprazole 30 mg together with amoxicillin 1000 mg three times daily (every 8 hours) for 14 days. 4. Maintenance therapy following treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The duration of comparative clinical trials did not exceed 12 months. 5. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The duration of comparative clinical trials did not exceed 8 weeks. 6. Reduction of the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The duration of comparative clinical trials did not exceed 12 weeks. 7. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks 8. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. 9. Maintenance therapy following treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. 10. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome Lansoprazole dosing for pathological hypersecretory conditions should be individualized for each patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of up to 90 mg per administration twice daily have been given. If the daily dose exceeds 120 mg, it should be divided. Elderly patients Since clearance of this medicine is reduced in elderly patients, dosage adjustment is required. Do not exceed a daily dose of 30 mg. Patients with hepatic impairment Because the metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer cautiously, including consideration of dosage adjustment.

Ingredients

Manufacturer
Samil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of peptic ulcers, treatment of gastroesophageal reflux disease, and suppression of pathological gastric acid hypersecretion

  • Active duodenal ulcers
  • active benign gastric ulcers
  • recurrence of duodenal ulcers
  • NSAID-induced gastric ulcers
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion
View approved original text

This medication is effective for the short-term treatment of active duodenal ulcers and active benign gastric ulcers. It is also used to eradicate Helicobacter pylori for the prevention of duodenal ulcer recurrence and is helpful in maintenance therapy after ulcer treatment. It is utilized for the treatment of gastric ulcers induced by non-steroidal anti-inflammatory drugs and to reduce the risk of occurrence. It is effective for the short-term treatment and maintenance therapy after treatment of symptoms related to gastroesophageal reflux disease and erosive esophagitis, and is used in conditions of pathological hypersecretion such as Zollinger-Ellison syndrome. This medication is beneficial for the treatment of various gastrointestinal diseases.

How to take

Adult dose

This medicine should be administered before meals. After opening, do not chew or crush this medicine before taking it. Adults 1. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. 2. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. 3. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer 1) Administer lansoprazole 30 mg together with clarithromycin 250 ∼ 500 mg and amoxicillin 1000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days, as needed. 2) Administer lansoprazole 30 mg together with amoxicillin 1000 mg three times daily (every 8 hours) for 14 days. 4. Maintenance therapy following treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The duration of comparative clinical trials did not exceed 12 months. 5. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The duration of comparative clinical trials did not exceed 8 weeks. 6. Reduction of the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The duration of comparative clinical trials did not exceed 12 weeks. 7. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks 8. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. 9. Maintenance therapy following treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. 10. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome Lansoprazole dosing for pathological hypersecretory conditions should be individualized for each patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of up to 90 mg per administration twice daily have been given. If the daily dose exceeds 120 mg, it should be divided. Elderly patients Since clearance of this medicine is reduced in elderly patients, dosage adjustment is required. Do not exceed a daily dose of 30 mg. Patients with hepatic impairment Because the metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer cautiously, including consideration of dosage adjustment.

Precautions

This medication should not be taken by individuals with allergic reactions to specific ingredients or those who have experienced severe side effects from this ingredient in the past. Additionally, pregnant women or patients taking certain antibiotics should not use this medication. Caution is required for the elderly, children, and nursing women, and they should consult a physician immediately if side effects occur. This medication can rarely cause severe allergic reactions or problems with the liver and kidneys; therefore, it should be discontinued and medical attention sought if unusual symptoms arise during use. Prolonged use may lead to nutrient deficiencies such as vitamin B12 deficiency or hypomagnesemia, requiring regular checks. This medication reduces gastric acid secretion, which may slightly increase the risk of bacterial infection in the stomach, and gastrointestinal symptoms like diarrhea or abdominal pain may occur. As there are many drug interactions, patients currently taking other medications must inform their doctor or pharmacist, especially when taking antibiotics, antiviral drugs, or anticoagulants. Dizziness, drowsiness, vision disturbances may occur, requiring caution when driving or operating machinery. In case of overdose, gastric lavage or symptomatic treatment may be necessary, and this medication should be kept out of the reach of children. This medication is to be used only in the minimum dose and for an appropriate duration, and if symptoms persist or worsen, medical consultation is necessary.

Side effects

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, generalized rash, facial swelling, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia, jaundice, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, membranous colitis, abdominal pain, frequent diarrhea, headache, diarrhea, abdominal distension, allergic reaction, back pain, weakness, candidiasis, neoplasm, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, malaise, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, abnormal stool, enteritis, gastritis, gastrointestinal abnormalities, gastrointestinal diseases, gastrointestinal bleeding, loss of appetite, gastric stones, pyloric spasm, cholelithiasis, constipation, dry mouth, thirst, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, discolored stool, bloating, gastric nodules, gastric adenomatous polyps, gastritis, upper gastrointestinal bleeding, hematemesis, increased appetite, increased saliva, rectal bleeding, stomatitis, tongue disease, glossitis, gum bleeding, postprandial somnolence, colitis, vomiting, nausea, candidiasis of the stomach, rectal disorders, rectal bleeding, diabetes mellitus, goiter, hypothyroidism, anemia, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone disorders, joint disorders, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia gravis, ptosis, synovitis, anxiety, amnesia, anxiety, apathy, confusion, depression, dizziness, syncope, hallucination, hemiplegia, worsening hostility, decreased libido, increased libido, neurosis, paresthesia, abnormal thought, convulsion, dementia, depersonalization, diplopia, hyperactivity, hypertonia, decreased sensation, insomnia, sleep disorder, drowsiness, tremor, acne, alopecia, pruritus, rash, urticaria, contact dermatitis, dry skin, nail disease, skin cancer, skin disorders, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disease, eye disease, glaucoma, abnormal olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, ocular pain, otitis media, taste distortion, tinnitus, visual field constriction, urinary disorders, renal pain, penile disorders, testicular disorders, urethral pain, polyuria, increased frequency of urination, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, hepatotoxicity, pancreatitis, taste disturbance, aplastic anemia, leukopenia, thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorder, urinary retention, increased AST, increased ALT, increased ALP, increased LDH, increased γ-GTP, fatigue, hyponatremia, increased total cholesterol, decreased total cholesterol, paralysis of the tongue and lips, limb paralysis, abdominal pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to store it at a temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Brownish-red round enteric-coated tablet

Package unit

28 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.